MICRO-CAPE 75

Descripción

Clopidogrel 75 mg | 30 coated tablets

Microcape 75mg

Antiplatelet agent. Antithrombotic.

Formula:

• Clopidogrel (as bisulfate) 75 mg.

Indications: 

• Acute coronary syndrome (ACS):For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], including patients who must be managed medically and those who must be managed with coronary revascularization, clopidogrel 75 mg has been shown to reduce the rate of a composite endpoint of cardiovascular death, myocardial infarction (MI), stroke, or refractory ischemia.
• For patients with ST-elevation myocardial infarction (STEMI), clopidogrel 75 mg has been shown to reduce the rate of death from any cause and the rate of a composite endpoint of death, reinfarction, or stroke. The benefit for patients undergoing primary percutaneous coronary intervention is unknown.

Directions:

• Acute coronary syndrome:Clopidogrel 75 mg may be administered with or without food. For patients with non-ST elevation ACS (UA/NSTEMI), initiate clopidogrel 75 mg with a single 300 mg oral loading dose and then continue with 75 mg once daily. Start aspirin (75-325 mg once daily) and continue in combination with clopidogrel 75 mg.
• For patients with STEMI, the recommended dose of clopidogrel 75 mg is 75 mg once daily orally, administered in combination with aspirin (75-325 mg once daily), with or without thrombolytics. Clopidogrel 75 mg may be initiated with or without a loading dose.
• Recent MI, recent stroke, or established peripheral arterial disease:The recommended dose of clopidogrel 75 mg is 75 mg once daily orally, with or without food.

Presentations:

• Package containing 30 coated tablets.